Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Lexicon Pharmaceuticals, Inc.

http://www.lexpharma.com/

Latest From Lexicon Pharmaceuticals, Inc.

IPOs Are Back: Liquid Biopsy, Cardio, Dialysis Firms Lead $1.5Bn Charge

Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.

Financing Analysis

Renalytix AI And AstraZeneca Collaborate To Improve Chronic Kidney Disease Outcomes

The companies will launch "precision medicine strategies" for chronic disease that use Renalytix' AI-enabled IVDs.

Deals Artificial Intelligence

Renalytix AI Launches Trial To Identify COVID-19 Patients With Kidney Injury

The Mount Sinai spin-off believes its KindeyIntelX system can identify COVID-19 patients at high risk for long-term kidney damage.

Coronavirus COVID-19 In Vitro Diagnostics

Deal Watch: AbbVie Exits Inherited CRISPR-Cas9 Team-Up With Editas

Editas regains rights to ocular programs first partnered with Allergan in 2017. Newly public F-star will focus on bispecific antibodies for cancer, TriSalus acquires oncology candidate from Dynavax.

Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
UsernamePublicRestriction

Register